This paper is only available as a PDF. To read, Please Download here.
Highlights:
- •Graves’ disease treatment with beta-blocker therapy
- •Development of pancreatitis following propranolol use
- •Biochemical and clinical resolution of pancreatitis with propranolol discontinuation
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of DiabetesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Accepted:
January 4,
2023
Received in revised form:
November 7,
2022
Received:
June 30,
2022
Publication stage
In Press Journal Pre-ProofIdentification
Copyright
© 2023 Canadian Diabetes Association.
